Pain Measurement Study for People with IBS
Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
- Age
- 18 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 120 (estimated)
- Sponsor
- University of Connecticut · Other
This trial is looking for people with Irritable Bowel Syndrome (IBS) who experience abdominal pain. Participants will help evaluate a new method for measuring pain and its effectiveness in treating IBS.
You may be able to join if
- I have been diagnosed with IBS by a healthcare provider.
- I am currently experiencing abdominal pain.
- I am between 18 and 50 years old.
- I can read and speak English.
- I have daily access to a computer with internet.
You may not be able to join if
- I have other chronic pain conditions not related to IBS.
- I have celiac disease or inflammatory bowel disease.
- I have diabetes.
- I have serious mental health conditions.
- I am pregnant or have had a baby in the last 3 months.
- I regularly use opioids or other illegal substances.
- I have had COVID-19 and have not fully recovered.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.
Loading trial locations…